Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Fecal RP Metabolomics Alzheimer's

ABSTRACT: Wildtype and transgenic mice were treated with or without Bacteroides fragilis and frontal cortex samples were extracted for LC-MS analysis. Standards were run alongside samples for targeted analysis. LC-MS was conducted in positive mode with RP separation and a C18 column. Sulfadimethoxine was used as an internal standard.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Mus <mouse, Genus> (ncbitaxon:10088)

SUBMITTER: Allegra Aron

PROVIDER: MSV000095774 | GNPS |

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS - Alzheimer's B. fragilis Mouse Frontal Cortex (RP) FINAL

Project description:Wildtype and transgenic mice were treated with or without Bacteroides fragilis and frontal cortex samples were extracted for untargeted LC-MS analysis. LC-MS was conducted in positive mode with RP separation and a C18 column. Sulfadimethoxine was used as an internal standard.

| MSV000099337 | GNPS

GNPS - Alzheimer's Bacteroides HILIC Frontal Cortex

Project description:Wildtype and transgenic mice were treated with or without Bacteroides fragilis and frontal cortex samples were extracted for untargeted LC-MS analysis. LC-MS was conducted in positive mode with HILIC separation and a BEH amide column using the method described in (Lai, 2021). Fecal samples were spiked with labeled tyrosine (L-tyrosine (3,3-D2)).

2025-04-30 | MSV000097768 | GNPS

GNPS - Alzheimer's B. fragilis Mouse Frontal Cortex (HILIC) FINAL

Project description:Wildtype and transgenic mice were treated with or without Bacteroides fragilis and frontal cortex samples were extracted for untargeted LC-MS analysis. LC-MS was conducted in positive mode with HILIC separation and a BEH amide column using the method described in (Lai, 2021). Fecal samples were spiked with labeled tyrosine (L-tyrosine (3,3-D2)).

2025-05-29 | MSV000098035 | GNPS

GNPS - Alzheimer's Mouse Brain Tissue HILIC Metabolomics

Project description:Healthy and Alzheimer's diseased mice were treated with/without Bacteroides fragilis gut bacteria. Frontal cortex and hippocampus brain tissue were analyzed for metabolites using untargeted LC-MS.

2025-04-01 | MSV000097475 | GNPS

GNPS - Alzheimer's Bacteroides HILIC Hippocampus

Project description:Wildtype and transgenic mice were treated with or without Bacteroides fragilis and hippocampus samples were extracted for untargeted LC-MS analysis. LC-MS was conducted in positive mode with HILIC separation and a BEH amide column using the method described in (Lai, 2021). Fecal samples were spiked with labeled tyrosine (L-tyrosine (3,3-D2)).

2025-04-30 | MSV000097771 | GNPS

GNPS - Alzheimer's Bacteroides HILIC Serum

Project description:Wildtype and transgenic mice were treated with or without Bacteroides fragilis and brain serum samples were extracted for untargeted LC-MS analysis. LC-MS was conducted in positive mode with HILIC separation and a BEH amide column using the method described in (Lai, 2021). Fecal samples were spiked with labeled tyrosine (L-tyrosine (3,3-D2)).

2025-04-30 | MSV000097772 | GNPS

GNPS - Alzheimer's Bacteroides HILIC Fecal

Project description:Wildtype and transgenic mice were treated with or without Bacteroides fragilis and fecal samples were extracted for untargeted LC-MS analysis. LC-MS was conducted in positive mode with HILIC separation and a BEH amide column using the method described in (Lai, et. al. ACS Omega. 2021.). Fecal samples were spiked with labeled tyrosine (L-tyrosine (3,3-D2)).

2025-05-09 | MSV000097845 | GNPS

Expression analysis of Bacteroides fragilis NCTC 9343 delta-ungD1 delta-ungD2

Project description:Investigation of whole genome gene expression level changes in a Bacteroides fragilis NCTC 9343 delta-ungD1 delta-ungD2 double mutant compared to the wild-type strain. Keywords: expression analysis A six chip study using total RNA recovered from three separate wild-type cultures of Bacteroides fragilis NCTC 9343 and three separate cultures of a double mutant strain, Bacteroides fragilis NCTC 9343 delta-ungD1 delta-ungD2, in which ungD1 (BF1706) and ungD2 (BF2848) are deleted. Each chip measures the expression level of 4,302 genes from Bacteroides fragilis NCTC 9343 and the associated plasmid pBF9343 with fourteen 24-mer probe pairs (PM/MM) per gene, with three-fold technical redundancy.

2010-04-15 | E-GEOD-7450 | biostudies-arrayexpress

Effect of Bacteroides fragilis administration on microglia in WT and the APP-PS1 model of Alzheimer's disease [Bfrag]

Project description:The gut microbiota and innate immune system play critical roles in Alzheimer’s disease (AD). Bacteroides is elevated in AD patients and correlates with cerebrospinal fluid levels of Aβ and tau. We found that increased amyloid-β (Aβ) plaques in Bacteroides fragilis treated APP/PS1-21 mice were associated with altered cortical expression Aβ processing genes. B. fragilis suppressed peripheral CD4+ T cell production of GM-CSF and IL-4 and transcriptional changes in microglia related to GM-CSF and IL-4 signaling, phagocytosis, and protein degradation. Furthermore, B. fragilis impaired the microglial uptake of intracranially injected Aβ42, whereas Erysipelotrichaceae strains increased uptake. Depleting murine Bacteroidetes with metronidazole decreased amyloid load in aged 5xFAD mice, increased CD4+ T cell GM-CSF production, and activated microglial pathways related to cytokine signaling, phagocytosis and lysosomal degradation. These data suggest that the gut microbiome may contribute to AD pathogenesis by suppressing peripheral cytokines and microglia phagocytic function, leading to impaired immune-mediated Aβ clearance.

2024-10-12 | GSE215438 | GEO

Expression data from post mortem Alzheimer's disease brains

Project description:To identify molecular pathological alterations in AD brains, we performed interspecies comparative microarray analyses using RNAs prepared from postmortem human brain tissues donated for the Hisayama study and hippocampal RNAs from the triple-transgenic mouse model of AD (3xTg-AD) Three-way ANOVA of microarray data from frontal cortex, temporal cortex and hippocampus with presence/absence of AD and vascular dementia, and sex, as factors revealed that the gene expression profile is most significantly altered in the hippocampi of AD brains. Comparative analyses of the brains of AD patients and a mouse model of AD showed that genes involved in non-insulin dependent DM and obesity were significantly altered in both, as were genes related to psychiatric disorders and Alzheimer’s disease. We prepared RNA samples from the gray matter of frontal and temporal cortices and hippocampi derived from 88 postmortem brains, among which 26 cases were pathologically diagnosed as having AD or an AD-like disorder. High-quality RNA (RIN≧6.9) samples were subjected to microarray analysis using the Affymetrix Human Gene 1.0 ST platform, and only those results that passed examinations for quality assurance and quality control of the Human Gene 1.0 ST arrays were retrieved. In total, we obtained gene expression profiles from the following samples: 33 frontal cortex samples, among which 15 were from AD patients; 29 temporal cortex samples, among which 10 were from AD patients; 17 hippocampus samples, among which seven were from AD patients

2013-04-17 | E-GEOD-36980 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data